NTRK2 and cancer: Oncogenic fusion genes involving the NTRK family (NTRK1, NTRK2, or NTRK3) have been identified in various cancers, and a few NTRK-TKIs have been effective against the NTRK-rearrangement-positive cancers in clinical trials21,22.